Eli Lilly and Co (NYSE:LLY) under-valued by 11%
| Website | https://www.lilly.com/ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2020 |
| Market Cap | $175,495,528,448 |
| Beta | 0.21783 |
| Average Volume | $4,156,796 |
| Last Dividend | 3.07% |
| Price on Feb 17, 2021 | $183.00 |
| Autochartist™ Valuation | $203.66 |
| Conclusion |
11% under-valued |
| Download Report |
